<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Proteases on Michael’s Domain</title><link>https://jeltsch.org/en/tags/proteases/</link><description>Recent content in Proteases on Michael’s Domain</description><generator>Hugo</generator><language>en-us</language><copyright>Copyright © 2002 - 2026 Michael Jeltsch.</copyright><lastBuildDate>Fri, 24 Jul 2026 00:18:18 +0300</lastBuildDate><atom:link href="https://jeltsch.org/en/tags/proteases/index.xml" rel="self" type="application/rss+xml"/><item><title>Preprint and Open Review</title><link>https://jeltsch.org/en/biology/</link><pubDate>Mon, 18 Jan 2021 00:00:00 +0000</pubDate><guid>https://jeltsch.org/en/biology/</guid><description>&lt;p&gt;In February 2020, Henry Kwok from the University of Macau asked me whether I want to contribute to an upcoming special issue in the journal &lt;em&gt;Biology&lt;/em&gt;*. He was guest editing this special issue on the topic of &lt;em&gt;Proteases — From Basic Structure to Function to Drug Design as Targeted Therapy&lt;/em&gt;. The topic is exactly what we are researching at the moment: whether we can target the lymphangiogenic growth factor VEGF-C via its activating proteases. So I tentatively agreed to contribute a review on the activation of VEGFs. We decided for the first time to simultaneously make the manuscript available as a preprint AND to ask for open review. Open review means that the reviewers&amp;rsquo; comments and our rebuttal will be published together with the article if the article is accepted.&lt;/p&gt;</description></item></channel></rss>